Stay updated on Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.

Latest updates to the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page
- ChecktodayChange DetectedThe page has been updated to reflect a new version, v2.16.8, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
- Check7 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.6, replacing the previous version v2.16.5. Additionally, the phrasing regarding the last update has been changed from 'Estimated' to a definitive statement.SummaryDifference0.1%
- Check14 days agoChange DetectedThe service alert has been updated to reflect a planned maintenance period starting on July 25th, during which most services will be unavailable for over 24 hours, replacing the previous alert for July 26th with a shorter downtime.SummaryDifference0.5%
- Check22 days agoChange DetectedThe web page now includes a service alert regarding planned maintenance on July 26th, indicating that most services will be unavailable for over 12 hours starting at 6 AM EDT.SummaryDifference0.4%
- Check29 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.5%
- Check36 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
Stay in the know with updates to Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.